Arcosa (ACA)
(Delayed Data from NYSE)
$103.86 USD
+0.70 (0.68%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $103.84 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$103.86 USD
+0.70 (0.68%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $103.84 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Zacks News
Earnings Preview: Arcosa (ACA) Q2 Earnings Expected to Decline
by Zacks Equity Research
Arcosa (ACA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TopBuild (BLD) Banks on Acquisitions, Material Costs High
by Zacks Equity Research
Solid growth across the business, favorable industry parameters and strategic initiatives are aiding TopBuild (BLD) to generate higher profits despite high material cost.
New Strong Sell Stocks for June 17th
by Zacks Equity Research
CSIQ, SI, TTEC, ACA, and TUP have been added to the Zacks Rank #5 (Strong Sell) List on June 17, 2021
Arcosa (ACA) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Arcosa (ACA) delivered earnings and revenue surprises of 66.67% and 0.23%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Arcosa (ACA) Q1 Earnings Expected to Decline
by Zacks Equity Research
Arcosa (ACA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ACA vs. ROAD: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ACA vs. ROAD: Which Stock Is the Better Value Option?
7 Low Price-to-Sales Stocks With Growth Potential to Own Now
by Zacks Equity Research
A stock with a lower price-to-sales ratio is a more suitable investment than a stock with a high price-to-sales ratio.
Arcosa (ACA) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Arcosa (ACA) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Arcosa (ACA) Q3 Earnings Top Estimates
by Zacks Equity Research
Arcosa (ACA) delivered earnings and revenue surprises of 17.24% and -2.20%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Masco (MAS) Q3 Earnings & Revenues Beat Estimates, Rise Y/Y
by Zacks Equity Research
Masco's (MAS) third-quarter results gained from sturdy performance across both Plumbing Products and Decorative Architectural Products segments.
Armstrong World (AWI) Q3 Earnings Beat Estimates, Fall Y/Y
by Zacks Equity Research
Armstrong World's (AWI) third-quarter results are hurt by lower volume and unfavorable AUV.
Analysts Estimate Arcosa (ACA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Arcosa (ACA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Low Leverage Stocks to Buy for a Healthy Portfolio
by Aparajita Dutta
Although debt financing is more popular compared to equity financing, it remains a feasible option as long as the companies succeed in generating higher rate of return than the interest rate
7 Valuable Low Price-to-Sales Stocks With Growth Opportunity
by Rajani Lohia
A stock's price-to-sales ratio reflects how much investors are paying for each dollar of revenues generated by a company.
Arcosa (ACA) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Arcosa (ACA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks.com featured highlights include: LHCG, DKS, HMN, ACA and LL
by Zacks Equity Research
Zacks.com featured highlights include: LHCG, DKS, HMN, ACA and LL
Buy These 5 Low Leverage Stocks as Market Volatility Persists
by Aparajita Dutta
A total rebound of the market to the pre-pandemic levels is highly unlikely in the near future. Therefore, while choosing stocks, a prudent investor should avoid debt-ridden stocks
When Does Market Timing Actually Work? - September 30, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
ACA or AWI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ACA vs. AWI: Which Stock Is the Better Value Option?
Why TopBuild (BLD) is Rallying Significantly Post Q2 Earnings
by Zacks Equity Research
Solid growth across the business, favorable industry parameters and strategic initiatives are aiding TopBuild (BLD) to generate higher profits.
ACA vs. AWI: Which Stock Is the Better Value Option?
by Zacks Equity Research
ACA vs. AWI: Which Stock Is the Better Value Option?
The Market Timing Secrets No One Talks About - September 10, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
The Keys to Successfully Timing the Markets - August 21, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
ACA vs. AWI: Which Stock Is the Better Value Option?
by Zacks Equity Research
ACA vs. AWI: Which Stock Is the Better Value Option?
Installed Building Expands Reach in South Carolina & Georgia
by Zacks Equity Research
Installed Building Products' (IBP) acquisition strategy is set to boost geographical boundaries and product offerings.